Monoclonal gammopathy in association with allergic disorders of the skin and respiratory tract

Allergy and Asthma Proceedings

Volumn 27, Issue 2, 2006, Pages 130-139

  Silverman, Bernard A ^a   Ku, Min ^a   Kapur, Prianka ^a   Schneider, Arlene T ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CASE REPORT; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PARAPROTEINEMIA; RESPIRATORY TRACT ALLERGY; URTICARIA;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; PARAPROTEINEMIAS; RESPIRATORY HYPERSENSITIVITY; URTICARIA;

EID: 33646488846     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Kyle RA. Monoclonal gammopathy of undetermined significance. Natural history in 241 cases. Am J Med 64:814, 1978.
2. Lipsker D, Veran Y, Grunenberger F, et al. The schnitzler's syndrome: Four new cases and review of the literature. Medicine 80:37-44, 2001.
3. Winckelmann G, Nagel HG, Maier R, and Reuther G. The schnitzler syndrome as a cause of recurrent fever of unknown origin. Dtsch Med Wochenschr 121:860-864, 1996.
4. De Waele S, Lecouvet FE, Malghem J, et al. Schnitzler's syndrome: An unusual cause of bone pain with suggestive imaging features. AJR 175:1325-1327, 2000.
5. Sanchez G, Ano M, Garcia-Aviles C, and Dieguez I. Schnitzler syndrome: A case study. J Investig Allergol Clin Immunol 10:41-43, 2000.
6. Puddu P, Cianchini G, Girardelli CR, et al. Schnitzler's syndrome: Report of a new case and a review of the literature. Clini Exp Rheumatol 15:91-95, 1997.
7. Lim W, Shumak KH, Reis M, et al. Malignant evolution of schnitzler's syndrome-chronic urticaria and IgM monoclonal gammopathy: A report of a new case and a review of the literature. Leuk Lymphoma 43:181-186, 2002.
8. Kyle RA, Therneau TM, Rajkumar SV, et al. A long term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 346:564, 2002.
9. Chevailler A, Arlaud G, Ponard D, et al. C-1 inhibitor binding monoclonal immunoglobulins in three patients with acquired angioneurotic edema. J Allergy Clin Immunol 97:998-1008, 1996.
10. Cicardi M, Bisiani G, Cugno M, et al. Autoimmune C1 inhibitor deficiency: Report of eight patients. Am J Med 95:169-175, 1993.
11. Nagy L, Hannema A, and Swaak A. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus, secondary anti-phospolipid syndrome and IgM monoclonal paraproteinemia. Clin Rheumatol 18:56-58, 1999.
12. Moller-Peterson J, and Schmidt EB. Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy. Scand J Haematol 119:706, 2002.
13. Carter A, and Tatarsky I. The pathophysiologic significance of benign monoclonal gammopathy: A study of 64 cases. Br J Haematol 46:565, 1980.
14. Blade J, Lopez-Guillermo A, Rozman C, et al. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haemotol 82:391, 1992.
15. Kyle RA. "Benign" monoclonal gammopathy after 20 to 35 years of follow up. Mayo Clin Proc 68:26, 1993.
16. Kyle RA, Finkelstein S, Elveback LR, and Kurland LT. Incidence of monoclonal proteins in a Minnesota community with a cluster of multiple myeloma. Blood 40:719, 1972.
17. Axelsson U. A 20-year follow-up study of 64 subjects with M-components. Acta Med Scand 219:519-522, 1986.
18. Neriishi K, Nakashima E, and Suzuki G. Monoclonal gammopathy of undetermined significance in atomic bomb survivors: Incidence and transformation to multiple myeloma. Br J Haematol 121:405-410, 2003.
19. Saleun JP, Vicariot M, Deroff P, and Morin JF. Monoclonal gammopathies in the adult population of Finistere, France. J Clin Pathol 35:63-68, 1982 Jan.
20. Przybylki GK, Goldman J, Ng VL, et al. Evidence for early B-cell activation preceding the development of Epstein Barr Virus-negative acquired immunodeficiency syndrome-related lymphoma. Blood 88:4620-4629, 1996.
21. De Re V, De Vita S, Marzotto A, et al. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer 87:211-216, 2000.
22. Purtilo DT. Lymphotropic viruses, Epstein-Barr virus (EBV), and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency. AIDS Res (suppl 1):S1-S6, 1986.
23. Goldstein JA, and Bernstein RL. Burkitt's lymphoma and the role of Epstein-Barr virus. J Trop Pediatr 36:114-120, 1990.
24. Fonseca R, Bailey RJ, Ahmann GJ, et al. Genomic abnormalities in monoclonal gammopathy of undetermined significance. Blood 100:1417-1424, 2002.
25. Zandecki M, Lai JL, Genevieve F, et al. Several cytogenic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. Blood 90:3682-3690, 1997.
26. Pascual-Lopez M, Hernandez-Nunez A, Sanchez-Perez J, et al. Schnitzler's syndrome with monoclonal IgG kappa gammopathy: A good response to cyclosporin. J Eur Acad Dermatol Venereol 16:267-270, 2001.
27. Nashan D, Sunderkotter C, Bonsmann G, et al. Chronic urticaria, arthralgia, raised erythrocyte sedimentation rate, and IgG paraproteinaemia: A variant of schnitzler's syndrome? Br J Dermatol 133:132-134, 1995.
28. Daoud MS, Lust JA, Kyle RA, and Pittelkow MR. Monoclonal gammopathies and associated skin disorders. J Am Acad Dermatol 40:507-535, 1999.
29. Lauwers A, Chouvy V, Mosnier JF, et al. A case of schnitzler's syndrome with nodular regenerative hyperplasia of the liver. Rev Rhum Engl Ed 66:281-283, 1999.
30. Janier M, Bonvalet D, Blanc MF, et al. Chronic urticaria and macroglobinemia (schnitzler's syndrome): Report of two cases. J Am Acad Dermatol 20:206-211, 1989.
31. Verret JL, Leclech C, Rousselet MC, et al. Schnitzler syndrome and waldenstrom disease. Fatal outcome of the original case. Ann Dermatol Venereol 120:459-460, 1993.
32. Govindaraju S, Brochot P, Ringot AC, et al. Chronic urticaria- macroglobulinemia (Schnitzler syndrome): Developing to IgM myeloma. Apropos of a case. Rev Med Interne 14:780-783, 1993.
33. Sheffer AL, Austen KF, Rosen FS, and Fearon DT. Acquired deficiency of the inhibitor of the first component of complement: Report of five additional cases with commentary on the syndrome. J Allergy Clin Immunol 75:640-646, 1985.
34. Geha RS, Quinti I, Austen KF, et al. Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins. N Engl J Med 312:534-540, 1985.
35. Alsenz J, and Loos M. The acquired C1-INH deficiencies with autoantibodies (AAE type II). Behring Inst Mitt 84:165-172, 1989.
36. Jazwinska EC, Gatenby PA, Dunckley H, and Serjeantson SW. C1 inhibitor functional deficiency in systemic lupus erythematosus (SLE). Clin Exp Immunol 92:268-273, 1993.
37. Zuraw BL. Urticaria, angioedema, and autoimmunity. Clin Lab Med 17:559-59, 1997.
38. Boyce TG, Swerdlow DL, and Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 333:364-368, 1995.
39. Stollerman GH, Lewis AJ, Schultz I, and Taranta A. Relationship of the immune response to group A streptococci to the cause of acute, chronic and recurrent rheumatic fever. Am J Med 20:163-169, 1956.
40. Bellotti V, Gamba G, Merlini G, et al. Study of three patients with monoclonal gammopathies and "lupus-like" anticoagulants. Br J Haematol 73:221-227, 1989.
41. Stern JJ, Ng RH, Triplett DA, and McIntyre JA. Incidence of antiphospholipid antibodies in patients with monoclonal gammopathy of undetermined significance. Am J Clin Pathol 101: 471-474, 1994.
42. Sharma AM, Fried J, and Sharma OP. Monoclonal gammopathy of undetermined significance in sarcoidosis. Two case reports. Sarcoidosis 9:70-72, 1992.
43. Arnulf B, Bengoufa D, Sarfati E, et al. Prevalence of monoclonal gammopathy in patients with primary hyperparathyroidism: A prospective study. Arch Intern Med 162:464-7, 2002.
44. Nocente R, Cammarota G, Gentioloni Silveri N, et al. A case of Swseet's syndrome associated with monoclonal immunoglobulin of IgG-lambda type and p-ANCA positivity. Panminerva Med 44:149-150, 2002.
45. Jonsson V, Svendsen B, Vorstrup S, et al. Multiple autoimmune manifestations in monoclonal gammopathy of undetermined significance and chronic lymphocytic leukemia. Leukemia 10: 327-332, 1996.
46. Noblie-Orazio E, Casellato C, and Di Troia A. Neuropathies associated with IgG and IgA monoclonal gammopathy. Rev Neurol 158:979-987, 2002.
47. Stubbs EB Jr, Lawlor MW, Richards MP, et al. Anit-neurofilament antibodies in neuropathy with monoclonal gammopathy of undetermined significance produce experimental motor nerve conduction block. Acta Neuropathol 105:109-116, 2003.
48. Lawlor MW, Holve S, and Stubbs EB Jr. Assessment of serum-mediated neurotoxicity in Navajo neuropathy. Electromyogr Clin Neurophysiol 40:211-214, 2000.
49. Hamazaki K, Baba M, Hasegawa H, et al. Chronic hepatitis C associated with monoclonal gammopathy of undetermined significance. J Gastroenterol Hepatol 18:459-460, 2003.
50. Bergenbrant S, Osterborg A, Holm G, et al. Anti-idiotypic antibodies in patients with monoclonal gammopathies: Relation to the tumour load. Br J Haematol 78:66-70, 1991.
51. Payne DA, Chan TS, Patten B, and Tyring SK. Extrachomosomal human papillomavirus (HPV) in multiple myeloma and monoclonal gammopathy of unknown significance (MGUS) patients. Anticancer Res 15:2213-2215, 1995.
52. Malik AA, Ganti AK, Potti A, et al. Role of Helicobacter pylori infection in the incidence and clinical course of monoclonal gammopathy of undetermined significance. Am J Gastroenterol 97:1371-1374, 2002.
53. Stone SA, Lennette ET, Newman JT, et al. Serologic prevalence of antibody to human herpesvirus type 8 in patients with various monoclonal gammopathies. Leuk Lympoma 37:197-302, 2000.
54. Discalzi G, Cioci I, Ganio L, et al. Multiple myeloma and occupational risk factors: A case-control study. Med Lav 82:248-252, 1991.
55. Morris PD, Koepsell TD, Daling JR, et al. Toxic substance exposure and multiple myeloma: A case-control study. J Natl Cancer Inst 76:987-994, 1986.
56. Pasqualetti P, Collacciani A, and Casale R. Risk of monoclonal gammopathy of undetermined significance: A case-referent study. Am J Hematol 52:217-220, 1996.
57. Stiehm ER. Disorders of the IgA system. In Immunologic Disorders in Infants and Children, 4th ed. Cunningham-Rundles C and Stiehmer IN (Eds.). Philadelphia: W. B. Saunders Co., 423-437, 1996.